World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
80
Citations
35528
World Ranking
1597
National Ranking
796

Medicine

D-Index
80
Citations
35528
World Ranking
16905
National Ranking
8479

Mark Connors publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mark Connors sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 184 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mark Connors D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark Connors sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mark Connors is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their academic work centers on immunology, microbiology, and medicine, with a particular focus on HIV research, immune cell function, and infectious diseases.

The primary fields of study encompass Immunology and Microbiology and Medicine, with subfields including Immunology, Virology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging, and Epidemiology.

The topics covered extensively in their research include:

  • HIV Research and Treatment
  • Immune Cell Function and Interaction
  • Monoclonal and Polyclonal Antibodies Research
  • T-cell and B-cell Immunology
  • HIV/AIDS Drug Development and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses

Mark Connors has published multiple papers, among which these recent works stand out:

  • "SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn," 2021, Annals of Internal Medicine
  • "A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity," 2021, Journal of Clinical Investigation
  • "VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage," 2020, Cell Host & Microbe
  • "Evaluating a New Class of AKT/mTOR Activators for HIV Latency-Reversing Activity Ex Vivo and In Vivo," 2021, Journal of Virology
  • "High-Throughput B Cell Epitope Determination by Next-Generation Sequencing," 2022, Frontiers in Immunology

Frequent collaboration is evident with several coauthors, including John R. Mascola, Peter D. Kwong, Stephen A. Migueles, Nicole A. Doria-Rose, and Tongqing Zhou.

The prominent journals and publication venues representing their work include UNC Libraries, Journal of Virology, Frontiers in Immunology, Nature Communications, and Science Translational Medicine.

Best Publications

  • HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells

    Michael R. Betts;Martha C. Nason;Sadie M. West;Stephen C. De Rosa

  • Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

    Xueling Wu;Zhi Yong Yang;Yuxing Li;Carl Magnus Hogerkorp

  • HIV preferentially infects HIV-specific CD4 + T cells

    Daniel C. Douek;Jason M. Brenchley;Michael R. Betts;David R. Ambrozak

  • HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

    Stephen A. Migueles;M. Shirin Sabbaghian;W. Lesley Shupert;Maria P. Bettinotti

  • Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

    Jason M. Brenchley;Nitin J. Karandikar;Michael R. Betts;David R. Ambrozak

  • HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

    Stephen A. Migueles;Alisha C. Laborico;W. Lesley Shupert;M. Shirin Sabbaghian

  • Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

    Johannes F. Scheid;Hugo Mouquet;Niklas Feldhahn;Michael S. Seaman

  • Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

    Jinghe Huang;Gilad Ofek;Leo Laub;Mark K. Louder

  • Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing

    John R. Mascola;Gary Nabel;Barton F. Haynes;Xueling Wu

  • HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.

    Christine J. Pitcher;Claudia Quittner;Dolores M. Peterson;Mark Connors

  • Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1

    Maureen P. Martin;Ying Qi;Xiaojiang Gao;Eriko Yamada

  • Structure and immune recognition of trimeric pre-fusion HIV-1 Env

    Marie Pancera;Tongqing Zhou;Aliaksandr Druz;Ivelin S. Georgiev

  • Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control

    Stephen A. Migueles;Christine M. Osborne;Cassandra Royce;Alex A. Compton

  • HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.

    M Connors;J A Kovacs;S Krevat;J C Gea-Banacloche

  • Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques

    T Matano;R Shibata;C Siemon;M Connors

  • Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells.

    B L Levine;W B Bernstein;M Connors;N Craighead

  • Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.

    M Connors;N A Giese;A B Kulkarni;C Y Firestone

  • T-Cell Subsets That Harbor Human Immunodeficiency Virus (HIV) In Vivo: Implications for HIV Pathogenesis

    Jason M. Brenchley;Brenna J. Hill;David R. Ambrozak;David A. Price

  • Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface

    Jinghe Huang;Byong H. Kang;Marie Pancera;Jeong Hyun Lee

  • Broad HIV-1 neutralization mediated by CD4-binding site antibodies

    Yuxing Li;Stephen A Migueles;Brent Welcher;Krisha Svehla

Frequent Co-Authors

Stephen A. Migueles
Stephen A. Migueles National Institutes of Health
John R. Mascola
John R. Mascola ModeX Therapeutics
Nicole A. Doria-Rose
Nicole A. Doria-Rose National Institute of Allergy and Infectious Diseases
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
Mark K. Louder
Mark K. Louder National Institute of Allergy and Infectious Diseases
Ivelin S. Georgiev
Ivelin S. Georgiev Vanderbilt University Medical Center
Sijy O'Dell
Sijy O'Dell National Institute of Allergy and Infectious Diseases
Claire W. Hallahan
Claire W. Hallahan National Institute of Allergy and Infectious Diseases
Krisha McKee
Krisha McKee National Institute of Allergy and Infectious Diseases
Robert T. Bailer
Robert T. Bailer National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens numerous doors in healthcare and research, but it also complements various allied health professions. Many students explore related online degrees to expand their expertise and career options. For those interested in nursing, finding the easiest absn program to get into can be a practical step toward entering the nursing field quickly while building a strong foundation in biological sciences.

If you're aiming for a hands-on healthcare role with quicker entry, consider the range of programs focused on nursing support. The easy admission lpn programs can provide a fast track into patient care while balancing work and study commitments.

For advanced practice nurses who want to specialize further, locating the easiest np program optimizes the pathway to becoming a licensed nurse practitioner. This degree enhances clinical decision-making and patient management skills, which are valuable in immunology-related healthcare services.

Moreover, for those passionate about mental health and immunological impacts on psychiatric conditions, exploring the best pmhnp programs online offers excellent clinical placements and specialized training opportunities in psychiatric mental health nurse practitioner roles.

Best Scientists Citing Mark Connors

Trending Scientists

Recently Published Articles